These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8527903)
1. The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis. Cortner J; Vande Woude GF; Rong S EXS; 1995; 74():89-121. PubMed ID: 8527903 [TBL] [Abstract][Full Text] [Related]
2. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. Woolf AS; Kolatsi-Joannou M; Hardman P; Andermarcher E; Moorby C; Fine LG; Jat PS; Noble MD; Gherardi E J Cell Biol; 1995 Jan; 128(1-2):171-84. PubMed ID: 7822413 [TBL] [Abstract][Full Text] [Related]
4. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Rong S; Segal S; Anver M; Resau JH; Vande Woude GF Proc Natl Acad Sci U S A; 1994 May; 91(11):4731-5. PubMed ID: 8197126 [TBL] [Abstract][Full Text] [Related]
5. Met expression and sarcoma tumorigenicity. Rong S; Jeffers M; Resau JH; Tsarfaty I; Oskarsson M; Vande Woude GF Cancer Res; 1993 Nov; 53(22):5355-60. PubMed ID: 7693339 [TBL] [Abstract][Full Text] [Related]
6. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Takayama H; LaRochelle WJ; Sharp R; Otsuka T; Kriebel P; Anver M; Aaronson SA; Merlino G Proc Natl Acad Sci U S A; 1997 Jan; 94(2):701-6. PubMed ID: 9012848 [TBL] [Abstract][Full Text] [Related]
7. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. Anastasi S; Giordano S; Sthandier O; Gambarotta G; Maione R; Comoglio P; Amati P J Cell Biol; 1997 Jun; 137(5):1057-68. PubMed ID: 9166406 [TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. Brinkmann V; Foroutan H; Sachs M; Weidner KM; Birchmeier W J Cell Biol; 1995 Dec; 131(6 Pt 1):1573-86. PubMed ID: 8522613 [TBL] [Abstract][Full Text] [Related]
9. The hepatocyte growth factor/scatter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells. Kolatsi-Joannou M; Woolf AS; Hardman P; White SJ; Gordge M; Henderson RM J Cell Sci; 1995 Dec; 108 ( Pt 12)():3703-14. PubMed ID: 8719877 [TBL] [Abstract][Full Text] [Related]
10. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Jeffers M; Rong S; Anver M; Vande Woude GF Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307 [TBL] [Abstract][Full Text] [Related]
11. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Zhu H; Naujokas MA; Park M Cell Growth Differ; 1994 Apr; 5(4):359-66. PubMed ID: 8043510 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Weimar IS; de Jong D; Muller EJ; Nakamura T; van Gorp JM; de Gast GC; Gerritsen WR Blood; 1997 Feb; 89(3):990-1000. PubMed ID: 9028331 [TBL] [Abstract][Full Text] [Related]
13. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642 [TBL] [Abstract][Full Text] [Related]
14. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization. Yerushalmi GM; Leibowitz-Amit R; Shaharabany M; Tsarfaty I Neoplasia; 2002; 4(6):510-22. PubMed ID: 12407445 [TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of HGF-SF and its role in cell motility and invasion. Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W EXS; 1993; 65():311-28. PubMed ID: 8380739 [TBL] [Abstract][Full Text] [Related]
16. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Rong S; Donehower LA; Hansen MF; Strong L; Tainsky M; Jeffers M; Resau JH; Hudson E; Tsarfaty I; Vande Woude GF Cancer Res; 1995 May; 55(9):1963-70. PubMed ID: 7728766 [TBL] [Abstract][Full Text] [Related]
17. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Cao B; Su Y; Oskarsson M; Zhao P; Kort EJ; Fisher RJ; Wang LM; Vande Woude GF Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7443-8. PubMed ID: 11416216 [TBL] [Abstract][Full Text] [Related]
18. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). To CT; Tsao MS Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803 [TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Rong S; Bodescot M; Blair D; Dunn J; Nakamura T; Mizuno K; Park M; Chan A; Aaronson S; Vande Woude GF Mol Cell Biol; 1992 Nov; 12(11):5152-8. PubMed ID: 1406687 [TBL] [Abstract][Full Text] [Related]
20. Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma. Kuhnen C; Tolnay E; Steinau HU; Voss B; Müller KM Virchows Arch; 1998 Apr; 432(4):337-42. PubMed ID: 9565343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]